BLOOD CT RES FOUNDATION has a total of 15 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are A & G PHARMACEUTICAL INC, RAPPAPORT FAMILY INST FOR RES and ONCOIMMUNIN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Basic materials chemistry | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Animal care | |
#7 | Therapeutic chemical compounds | |
#8 | Preservation of human bodies | |
#9 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Matsuyama Shigemi | 6 |
#2 | Wiedmer Therese | 4 |
#3 | Sims Peter J | 4 |
#4 | Sun Wseiyong | 3 |
#5 | Raife Thomas J | 2 |
#6 | Montgomery Robert R | 2 |
#7 | Haberichter Sandra L | 2 |
#8 | Visentin Gian | 1 |
#9 | Stout James G | 1 |
#10 | Moghaddam Manouchehr | 1 |
Publication | Filing date | Title |
---|---|---|
US2014315223A1 | Method of simultaneous detection of heparin-induced immunoglobulins types G, A, and M | |
AU2003225623A8 | Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells | |
AU2002326980A1 | Method of modulating or examining ku70 levels in cells | |
AU7721701A | Synthetic and recombinant substrates for the detection of the von willebrand factor-cleaving protease | |
US6204035B1 | Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids | |
US6172210B1 | DNA encoding phospholipid scramblase |